2023 Q2 Form 10-Q Financial Statement

#000149315223020629 Filed on June 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $233.3K $178.8K $219.7K
YoY Change 12.26% -18.65% 784.62%
Cost Of Revenue $59.83K $71.45K $93.86K
YoY Change -21.12% -23.88% 1237.04%
Gross Profit $173.5K $107.3K $125.9K
YoY Change 31.43% -14.75% 606.4%
Gross Profit Margin 74.36% 60.03% 57.29%
Selling, General & Admin $308.8K $166.7K $440.1K
YoY Change 12.63% -62.12% 214.72%
% of Gross Profit 177.94% 155.34% 349.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $73.39K $10.56K $78.21K
YoY Change 9.46% -86.5% 707.95%
% of Gross Profit 42.29% 9.84% 62.13%
Operating Expenses $1.168M $302.0K $518.4K
YoY Change 242.3% -41.73% 246.65%
Operating Profit -$994.3K -$194.7K -$392.5K
YoY Change 375.41% -50.39% 197.98%
Interest Expense $55.84K $34.94K $41.04K
YoY Change -114.72% -14.85% -120.89%
% of Operating Profit
Other Income/Expense, Net -$68.94K -$15.82K -$146.0K
YoY Change -18.98% -89.16%
Pretax Income -$1.063M -$210.5K -$497.4K
YoY Change 57.82% -57.68% 51.58%
Income Tax
% Of Pretax Income
Net Earnings -$1.063M -$210.5K -$497.4K
YoY Change 57.82% -57.68% 51.58%
Net Earnings / Revenue -455.57% -117.77% -226.36%
Basic Earnings Per Share -$0.79 $0.00 $0.00
Diluted Earnings Per Share -$0.79 -$0.17 -$1.489K
COMMON SHARES
Basic Shares Outstanding 1.896B shares 1.896B shares 334.1M shares
Diluted Shares Outstanding 1.347M shares 1.246M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.30K $210.00 $5.270K
YoY Change 102.95% -96.02% -88.63%
Cash & Equivalents $30.30K $206.00 $5.269K
Short-Term Investments
Other Short-Term Assets $26.71K $27.45K $500.00
YoY Change 591.97% 5389.4%
Inventory
Prepaid Expenses
Receivables $83.28K $126.9K $222.5K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $140.3K $154.5K $228.3K
YoY Change 0.35% -32.3% 337.45%
LONG-TERM ASSETS
Property, Plant & Equipment $150.0K $160.5K $212.5K
YoY Change -24.36% -24.46% 38.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.056M $7.000K $7.000K
YoY Change 14983.51% 0.0% -58.48%
Total Long-Term Assets $1.056M $1.129M $1.377M
YoY Change -19.2% -18.01% 397.4%
TOTAL ASSETS
Total Short-Term Assets $140.3K $154.5K $228.3K
Total Long-Term Assets $1.056M $1.129M $1.377M
Total Assets $1.196M $1.284M $1.606M
YoY Change -17.31% -20.04% 387.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.054M $3.079M $3.095M
YoY Change -0.84% -0.5% 4.77%
Accrued Expenses $160.5K $130.6K $323.8K
YoY Change -57.94% -59.67% -0.46%
Deferred Revenue $62.99K $62.99K
YoY Change
Short-Term Debt $660.6K $574.2K $398.7K
YoY Change 25.37% 44.01% 1182.37%
Long-Term Debt Due $660.6K $574.2K $872.9K
YoY Change -27.65% -34.22% -13.74%
Total Short-Term Liabilities $5.080M $4.991M $5.529M
YoY Change -12.78% -9.72% 14.49%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.080M $4.991M $5.529M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.080M $4.991M $5.529M
YoY Change -12.78% -9.72% 14.49%
SHAREHOLDERS EQUITY
Retained Earnings -$13.65M -$12.58M
YoY Change
Common Stock $881.00 $189.6K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.883M -$3.708M -$3.923M
YoY Change
Total Liabilities & Shareholders Equity $1.196M $1.284M $1.606M
YoY Change -17.31% -20.04% 387.89%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.063M -$210.5K -$497.4K
YoY Change 57.82% -57.68% 51.58%
Depreciation, Depletion And Amortization $73.39K $10.56K $78.21K
YoY Change 9.46% -86.5% 707.95%
Cash From Operating Activities -$52.94K -$67.30K -$195.9K
YoY Change -438.06% -65.64% 227.84%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $51.59K
YoY Change
Cash From Investing Activities $0.00 $51.59K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 83.03K -$20.70K 164.5K
YoY Change -1483.83% -112.58% 5.9%
NET CHANGE
Cash From Operating Activities -52.94K -$67.30K -195.9K
Cash From Investing Activities 0.000 $51.59K
Cash From Financing Activities 83.03K -$20.70K 164.5K
Net Change In Cash 30.09K -$36.41K $0.00
YoY Change 211.49% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$52.94K -$67.30K -$195.9K
Capital Expenditures
Free Cash Flow -$195.9K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001637866
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023Q1 DGWR Stock Issued During Period Value Issuance Of Common Stock Incentives For Officers And Directors
StockIssuedDuringPeriodValueIssuanceOfCommonStockIncentivesForOfficersAndDirectors
usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q1 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 DGWR Issuance Of Common Stock To Directors For Accrued Compensation
IssuanceOfCommonStockToDirectorsForAccruedCompensation
usd
CY2023Q1 us-gaap Property Plant And Equipment Useful Life Description Of Term Extensible Enumeration
PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration
http://fasb.org/us-gaap/2023#LeaseholdImprovementsMember
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option Equity Instruments Warrants Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionEquityInstrumentsWarrantsExpired
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssued
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2022 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsGranted
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2023Q1 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsGranted
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-56190
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
DEEP GREEN WASTE & RECYCLING, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1035174
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
260 Edwards Plz
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
#21266
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Saint Simons Island
CY2023Q1 dei Entity Address Country
EntityAddressCountry
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
31522
CY2023Q1 dei City Area Code
CityAreaCode
(833)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
304-7336
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
DGWR
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1896216952 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
206 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36616 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11325 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13453 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126887 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170954 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
27447 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
22267 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
154540 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
229837 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160531 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
179113 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
961703 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1024529 usd
CY2023Q1 us-gaap Deposits Assets
DepositsAssets
7000 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
7000 usd
CY2023Q1 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
1129234 usd
CY2022Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
1210642 usd
CY2023Q1 us-gaap Assets
Assets
1283774 usd
CY2022Q4 us-gaap Assets
Assets
1440479 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
574171 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
598251 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
784288 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
800818 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3079480 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3090211 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
130569 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
99869 usd
CY2023Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
97106 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
95429 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
157487 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
138173 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
62986 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
62986 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
105246 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
112710 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4991333 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4998447 usd
CY2023Q1 us-gaap Liabilities
Liabilities
4991333 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4998447 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1896216952 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1896216952 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1721740762 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1721740762 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
189622 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
172174 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8632780 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8589295 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12581961 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12371437 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3707559 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3557968 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1283774 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1440479 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
178763 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219741 usd
CY2023Q1 us-gaap Revenues
Revenues
178763 usd
CY2022Q1 us-gaap Revenues
Revenues
219741 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
71445 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
93864 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
107318 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
125877 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
166712 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
218538 usd
CY2023Q1 us-gaap Officers Compensation
OfficersCompensation
53400 usd
CY2022Q1 us-gaap Officers Compensation
OfficersCompensation
176259 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
10143 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
45342 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1618 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
73387 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
78210 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
302024 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
518349 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-194706 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-392472 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
7464 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
697777 usd
CY2023Q1 DGWR Loss On Conversions Of Debt
LossOnConversionsOfDebt
31903 usd
CY2022Q1 DGWR Loss On Conversions Of Debt
LossOnConversionsOfDebt
145972 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
43565 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12500 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
582761 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
34944 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
656739 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15818 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-104934 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210524 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-497406 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1868750285 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
334064636 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3557968 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60933 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210524 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3707559 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4305579 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4305579 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
20400 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
14652 usd
CY2022Q1 DGWR Stock Issued During Period Value Issuance Of Common Stock Incentives For Officers And Directors
StockIssuedDuringPeriodValueIssuanceOfCommonStockIncentivesForOfficersAndDirectors
143100 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
701571 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-497406 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-497406 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3923262 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3923262 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210524 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-497406 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
73387 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
78210 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
43565 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1618 usd
CY2023Q1 DGWR Gain Loss On Conversion Of Convertible Notes And Accrued Interest
GainLossOnConversionOfConvertibleNotesAndAccruedInterest
-31903 usd
CY2022Q1 DGWR Gain Loss On Conversion Of Convertible Notes And Accrued Interest
GainLossOnConversionOfConvertibleNotesAndAccruedInterest
-145972 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12500 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
582761 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
7464 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
697777 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
145259 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45685 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36593 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5180 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-8259 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14114 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15689 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30700 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7913 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
1677 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
1629 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
19314 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
81614 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-67299 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-195848 usd
CY2023Q1 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
51585 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51585 usd
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
300000 usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
140000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-20696 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
4498 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20696 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
164498 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36410 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31350 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36616 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36619 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
206 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5269 usd
CY2022Q1 DGWR Issuance Of Common Stock To Directors For Accrued Compensation
IssuanceOfCommonStockToDirectorsForAccruedCompensation
-20400 usd
CY2023Q1 DGWR Fair Value Of Common Stock Issued
FairValueOfCommonStockIssued
60933 usd
CY2022Q1 DGWR Fair Value Of Common Stock Issued
FairValueOfCommonStockIssued
701571 usd
CY2023Q1 us-gaap Notes Assumed1
NotesAssumed1
29030 usd
CY2022Q1 us-gaap Notes Assumed1
NotesAssumed1
474794 usd
CY2022Q1 DGWR Accrued Interest Satisfied
AccruedInterestSatisfied
-78870 usd
CY2023Q1 DGWR Loss On Conversions Of Convertible Notes Payable
LossOnConversionsOfConvertibleNotesPayable
31903 usd
CY2022Q1 DGWR Loss On Conversions Of Convertible Notes Payable
LossOnConversionsOfConvertibleNotesPayable
147907 usd
CY2022Q1 us-gaap Notes Payable
NotesPayable
140000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
238467 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_ziz1oHEvQAPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zggSNxaRHpx9">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DEEP GREEN WASTE &amp; RECYCLING, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>For the three months ended March 31, 2023 and 2022</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Unaudited)</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
351004 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
370254 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
190473 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
191141 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160531 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
179113 usd
CY2023Q1 us-gaap Depreciation
Depreciation
10562 usd
CY2022Q1 us-gaap Depreciation
Depreciation
15384 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1327258 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1327258 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-365555 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-302730 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
961703 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1024529 usd
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2022Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
175642 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
238467 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
174202 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
826778 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3079480 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3090211 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
574171 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
598251 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
574171 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
598251 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
784288 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
800818 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
105246 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
112710 usd
CY2023Q1 us-gaap Share Price
SharePrice
0.0002
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.000175
CY2022Q4 us-gaap Share Price
SharePrice
0.0002
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.000175
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5714286 shares
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44571 usd
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5714286 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
52000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
52000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
52000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
52000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
80000 shares
CY2020Q4 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
80000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
30000 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsExpired
-30000 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Warrant Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWarrantExpired
-50000 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Expired Two
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsExpiredTwo
-50000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
5000000 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsGranted
5000000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
5000000 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsExercised
5000000 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued
133333334 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsIssued
133333334 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
133333334 shares
CY2021Q4 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
133333334 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
133333334 shares
CY2022Q4 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
133333334 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
133333334 shares
CY2023Q1 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
133333334 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
133333334 shares
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-44210 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-104455 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
30504 usd
CY2023Q1 DGWR Income Tax Reconciliation Nontaxable Derivative Liability Expense
IncomeTaxReconciliationNontaxableDerivativeLiabilityExpense
1567 usd
CY2022 DGWR Income Tax Reconciliation Nontaxable Derivative Liability Expense
IncomeTaxReconciliationNontaxableDerivativeLiabilityExpense
146533 usd
CY2023Q1 us-gaap Income Tax Reconciliation Nondeductible Expense Depreciation And Amortization
IncomeTaxReconciliationNondeductibleExpenseDepreciationAndAmortization
2625 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Depreciation And Amortization
IncomeTaxReconciliationNondeductibleExpenseDepreciationAndAmortization
122380 usd
CY2023Q1 DGWR Nondeductible Loss On Conversions Of Convertible Notes Payable
NondeductibleLossOnConversionsOfConvertibleNotesPayable
-6700 usd
CY2022 DGWR Nondeductible Loss On Conversions Of Convertible Notes Payable
NondeductibleLossOnConversionsOfConvertibleNotesPayable
-30654 usd
CY2023Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
36262 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
67450 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2023Q1 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The net operating loss carryforward at March 31, 2023 for the years 2003 to 2017 expires in varying amounts from year 2023 to year 2037.
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
206 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
154540 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4991333 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12581961 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-67299 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-205894 usd

Files In Submission

Name View Source Status
0001493152-23-020629-index-headers.html Edgar Link pending
0001493152-23-020629-index.html Edgar Link pending
0001493152-23-020629.txt Edgar Link pending
0001493152-23-020629-xbrl.zip Edgar Link pending
dgwr-20230331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
dgwr-20230331_def.xml Edgar Link unprocessable
dgwr-20230331_cal.xml Edgar Link unprocessable
dgwr-20230331_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
dgwr-20230331_pre.xml Edgar Link unprocessable